WhiteHawk pens cybersecurity deals with US healthcare and a national utility

|

Published 10-OCT-2018 11:07 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

WhiteHawk Limited (ASX:WHK) today announced that it has signed two new proof of value (POV) cybersecurity contracts.

While the details of each customer and the commercial terms remain commercial in confidence given the nature of the risk reviews, WHK has revealed that the contracts signed are with major players within the US east coast utilities and US national healthcare sectors.

Each POV contract is for up to 40 of the customers’ supply chain companies (vendors) initially, with potential second stages involving over 1000 vendors — at an average potential revenue of $1500 to $5000 per vendor.

East coast US utility provider

The utility sector customer is managing a power grid that provides services to over 20% of all US electricity customers and brings in over US$30 billion in revenues each year.

In this initial stage, the contract involves up to 40 vendors with the potential to move to a second stage involving over 1000 vendors in 2019. The utilities’ industry is projected to spend US$1.7 billion on cyber security in 2017 according to Smart Energy International.

Today’s announcement comes after WHK earlier announced the appointment of Salmon Ventures as a utility sector partner.

WHK's latest customer channel focus is on the 3200+ power and water utilities across the US (regional power associations, regulators, and larger private utilities) who are all searching for how to gain continuous insight into and to address their cyber related risks.

As the utilities sector provides critical national infrastructure, identifying, tracking and addressing supply chain software and service vendors’ cyber risks is a critical.

National US healthcare provider

The healthcare customer is a US nationwide non-profit organisation that needs to be able to identify and track cyber risks from their supply chain vendors and protect the sensitive HIPPA information they are intrusted with.

HIPPA, or the Health Insurance Portability and Accountability Act, is a US law providing privacy standards to protect patients' medical records and other health information.

WHK will initially undertake up to 40 supply chain vendor reviews and can move to a second stage thereafter.

The healthcare sector is an important customer for WHK as the global cybersecurity market for healthcare is expected to reach close to US$11 billion by 2022, according to Grand View Research, Inc.

The importance of adequate cybersecurity in the healthcare sector was highlighted recently with the WannaCry cyber-attack on the UK’s National Health Service (NHS), which resulted in expensive emergency measures and the UK spending over £150 million in additional cyber security protection in response.

For each of these new contracts, WHK will undertake a risk rating and analysis scorecard on each vendor company to provide a risk snapshot back to the prime customer. This helps the prime customer to reprioritise and monitor their most critical vendor companies in their supply chain and streamline their third-party management program.

The process drives vendors that are in a prime company’s supply chain to WhiteHawk's Cybersecurity Exchange, to mitigate key cyber risks in real-time. Some of the current pipeline companies have supply chains of more than 5000 companies.

CEO Terry Roberts said, “Through these two Proof of Value contracts, WhiteHawk continues to directly demonstrate and validate the company’s cyber risk brand and deep expertise within the two new critical sectors of Healthcare and the Utilities who are top cyber threat targets.”

The company is now well placed to capture more contracts in both the healthcare sector and utilities with critical infrastructure, which have been the target of cyber-attacks. In addition to the healthcare and utilities sectors, WHK has a large pipeline of contracts in the US Government department space, financial sector, US Defense sector.

Note that any decision with regards to adding this stock to your portfolio should be taken with caution and professional financial advice sought.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X